Fertility Preservation in Young Adult Patients with Rectal Cancer: A Few Things to Consider
- PMID: 35962740
- PMCID: PMC9526485
- DOI: 10.1093/oncolo/oyac148
Fertility Preservation in Young Adult Patients with Rectal Cancer: A Few Things to Consider
Abstract
This article evaluates the toxicity and feasibility of gemcitabine/nab-paclitaxel/S-1 chemotherapy on a 21-day cycle in patients with locally advanced or metastatic pancreatic ductal adenocarcinoma, reporting dose-limiting toxicity and maximum tolerated dose of S-1 in this regimen.
Comment in
-
In Reply to "Fertility Preservation in Young Adult Patients With Rectal Cancer: A Few Things to Consider".Oncologist. 2022 Oct 1;27(10):e823-e824. doi: 10.1093/oncolo/oyac149. Oncologist. 2022. PMID: 35972333 Free PMC article.
Comment on
-
Fertility Preservation Discussions Between Young Adult Rectal Cancer Survivors and Their Providers: Sex-Specific Prevalence and Correlates.Oncologist. 2022 Jul 5;27(7):579-586. doi: 10.1093/oncolo/oyac052. Oncologist. 2022. PMID: 35427410 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
